HNRNPU Antisense RNA 1: A Potential Drug Target Or Biomarker (G284702)

Target Name: HNRNPU antisense RNA 1

NCBI ID: G284702

HNRNPU antisense RNA 1

Other Name(s): NCRNA00201 | C1orf199 | HNRNPU-AS1

HNRNPU Antisense RNA 1: A Potential Drug Target Or Biomarker

HNRNPU antisense RNA 1 (NCRNA00201) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. HNRNPU antisense RNA 1 is a unique molecule that is composed of a perfect double-stranded RNA structure. It has a length of 29.6 kilobases (kb) and an estimated molecular weight of 13.7 kilobases (kDa). HNRNPU antisense RNA 1 is expressed in most tissues and cells of the human body, and its level of expression varies depending on the specific cell type and the biological context in which it is encountered.

HNRNPU antisense RNA 1 is a double-stranded RNA molecule that is composed of a sequence of alternating free and closed double-stranded regions. The free-stranded regions of HNRNPU antisense RNA 1 are composed of a series of alternating between GAG and AUG cis -elements, while the closed double-stranded regions are composed of a series of AUG cis-elements. The overall structure of HNRNPU antisense RNA 1 is conserved in the sense that it has a complementary base pair sequence on the 5' end that is complementary to the 3' end of the RNA molecule.

HNRNPU antisense RNA 1 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. For example, studies have shown that HNRNPU antisense RNA 1 is involved in the regulation of cell cycle progression and the apoptosis process. . HNRNPU antisense RNA 1 has also been shown to play a role in the regulation of gene expression by binding to specific DNA sequences and affecting the activity of RNA polymerase II.

In addition to its role in cellular processes, HNRNPU antisense RNA 1 has also been shown to be a potential drug target or biomarker. Studies have shown that HNRNPU antisense RNA 1 can be inhibited by small molecules, including inhibitors of RNA binding proteins and small molecules that can alter the activity of RNA polymerase II. These studies suggest that HNRNPU antisense RNA 1 may be a promising target for small molecules that can be used to treat various diseases.

In conclusion, HNRNPU antisense RNA 1 is a unique and promising molecule that has been shown to play a role in various cellular processes. Its structure and function make it a potential drug target or biomarker for the treatment of various diseases. Further studies are needed to fully understand the role of HNRNPU antisense RNA 1 in cellular processes and its potential as a drug target or biomarker.

Protein Name: HNRNPU Antisense RNA 1

The "HNRNPU antisense RNA 1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPU antisense RNA 1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets